Lassa fever epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 15: Line 15:
Like other [[Viral hemorrhagic fever|hemorrhagic fevers]], Lassa fever can be transmitted directly from one human to another. It can be contracted by an airborne route or with direct contact with infected human blood, urine, or semen. Transmission through [[breast milk]] has also been observed.
Like other [[Viral hemorrhagic fever|hemorrhagic fevers]], Lassa fever can be transmitted directly from one human to another. It can be contracted by an airborne route or with direct contact with infected human blood, urine, or semen. Transmission through [[breast milk]] has also been observed.


About 15%-20% of hospitalized Lassa fever patients will die from the illness. It is estimated that the overall mortality rate is 1%, however during [[epidemic]]s mortality can climb as high as 50%. Also the mortality rate is higher, greater than 80%, when it occurs in pregnant women during their third trimester; fetal death also occurs in nearly all those cases.  Abortion decreases the risk of death to the mother.
About 15%-20% of hospitalized Lassa fever patients will die from the illness. It is estimated that the overall mortality rate is 1%, however during [[epidemic]]s mortality can climb as high as 50%. Also the mortality rate is higher, greater than 80%, when it occurs in pregnant women during their third trimester; fetal death also occurs in nearly all those cases.  Abortion decreases the risk of death to the mother.  It is estimated that the virus is responsible for about 5,000 deaths annually. The fever accounts for up to one third of deaths in hospitals within the affected regions and 10 to 16% of total cases.


==References==
==References==

Revision as of 18:22, 27 November 2012

Lassa fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Lassa fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lassa fever epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lassa fever epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lassa fever epidemiology and demographics

CDC on Lassa fever epidemiology and demographics

Lassa fever epidemiology and demographics in the news

Blogs on Lassa fever epidemiology and demographics

Directions to Hospitals Treating Lassa fever

Risk calculators and risk factors for Lassa fever epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

Lassa virus is zoonotic (transmitted from animals), and that it spreads to man from rodents, specifically multi-mammate rats (Mastomys natalensis). This is probably the most common rodent in equatorial Africa, ubiquitous in human households and eaten as a delicacy in some areas. In these rats infection is in a persistent asymptomatic state. The virus is shed in their excreta (urine and feces), which can be aerosolized. In fatal cases, Lassa fever is characterized by impaired or delayed cellular immunity leading to fulminant viremia.

The dissemination of the infection can be assessed by prevalence of antibodies to the virus in populations of:

  • Sierra Leone 8–52%
  • Guinea 4–55%
  • Nigeria approx. 21%

Like other hemorrhagic fevers, Lassa fever can be transmitted directly from one human to another. It can be contracted by an airborne route or with direct contact with infected human blood, urine, or semen. Transmission through breast milk has also been observed.

About 15%-20% of hospitalized Lassa fever patients will die from the illness. It is estimated that the overall mortality rate is 1%, however during epidemics mortality can climb as high as 50%. Also the mortality rate is higher, greater than 80%, when it occurs in pregnant women during their third trimester; fetal death also occurs in nearly all those cases. Abortion decreases the risk of death to the mother. It is estimated that the virus is responsible for about 5,000 deaths annually. The fever accounts for up to one third of deaths in hospitals within the affected regions and 10 to 16% of total cases.

References


Template:WikiDoc Sources